Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine

NCT01316406 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Palmar-Plantar Erythrodysesthesia Syndrome

Interventions

DRUG: ATH008

Sponsor

Advancell - Advanced In Vitro Cell Technologies, S.A.

Collaborators

[object Object]